Accreditation Information

Boston University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Boston University School of Medicine designates this live activity for a maximum of 12.5 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

SSuccessful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 12.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participantswill earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

The Continuing Nursing Education Provider Unit, Boston University School of Medicine is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

AAPA accepts certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 12.5 hours of Category I credits™ for completing this program.

The program has been submitted to ABCGN for GI-specific approval.

 

Objectives

At the conclusion of this activity, participants will be able to (or better able to):

  1. Determine the benefits and risks of biologic treatments in patients with IBD.
  2. Discuss the role of therapeutic drug monitoring.
  3. Describe how to treat the pregnant IBD patient.
  4. Discuss issues related to men’s health in IBD.
  5. Evaluate the role of diet in the control of IBD, and understand how diet affects microbiota.
  6. Review the role of diagnostic imaging and endoscopic biopsy in the diagnosis and monitoring of Crohn disease and UC.
  7. Identify the most current approaches to the management of postoperative recurrence in Crohn’s disease.
  8. Describe the medical and surgical approaches in patients with severe ulcerative colitis and pouchitis.
  9. Recognize the benefits of health maintenance (immunizations, psychosocial screening, and skeletal health assessment) in patients with Crohn’s disease and ulcerative colitis.
  10. Recognize how to effectively advocate for your patient when third party payors or specialty pharmacies deny care or access to needed treatments.
  11. Evaluate and treat extraintestinal manifestations in IBD including osteoporosis.

 

Target Audience

This course is designed for practicing gastroenterologists, pediatric gastroenterologists, colorectal surgeons, nurses and other healthcare professionals caring for patients with Crohn’s disease and ulcerative colitis.

 

Faculty Disclosure

Boston University School of Medicine asks all individuals, and their spouses/partners, involved in the development and presentation of Continuing Medical Education (CME) and Continuing Nursing Education (CNE) activities to disclose all relevant financial relationships with commercial interests. This information is disclosed to CME activity participants prior to the start of the educational activity. Boston University School of Medicine has procedures to resolve all conflicts of interest. In addition, faculty members are asked to disclose when any unapproved use of pharmaceuticals and devices is being discussed.